HEALTHPEAK PROPERTIES INC (DOC) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:DOC - US42250P1030 - REIT
18.04 USD
-0.15 (-0.82%)
18.04 USD
0 (0%)
Overall DOC gets a fundamental rating of 3 out of 10. We evaluated DOC against 128 industry peers in the Diversified REITs industry. There are concerns on the financial health of DOC while its profitability can be described as average. DOC is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
DOC had positive earnings in the past year.
DOC had a positive operating cash flow in the past year.
In the past 5 years DOC has always been profitable.
Each year in the past 5 years DOC had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -0.20%, DOC perfoms like the industry average, outperforming 41.41% of the companies in the same industry.
The Return On Equity of DOC (-0.51%) is comparable to the rest of the industry.
The Return On Invested Capital of DOC (2.23%) is comparable to the rest of the industry.
DOC had an Average Return On Invested Capital over the past 3 years of 2.19%. This is in line with the industry average of 3.06%.
The 3 year average ROIC (2.19%) for DOC is below the current ROIC(2.23%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.2% | ||
| ROE | -0.51% | ||
| ROIC | 2.23% |
ROA(3y)2.1%
ROA(5y)2.44%
ROE(3y)5.05%
ROE(5y)5.78%
ROIC(3y)2.19%
ROIC(5y)1.92%
1.3 Margins
In the last couple of years the Profit Margin of DOC has grown nicely.
DOC's Operating Margin of 18.19% is in line compared to the rest of the industry. DOC outperforms 42.97% of its industry peers.
DOC's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 60.08%, DOC is doing worse than 67.19% of the companies in the same industry.
In the last couple of years the Gross Margin of DOC has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.19% | ||
| PM (TTM) | N/A | ||
| GM | 60.08% |
OM growth 3Y-2.63%
OM growth 5Y-7.45%
PM growth 3Y-30.28%
PM growth 5Y20.4%
GM growth 3Y0.52%
GM growth 5Y-2.11%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DOC is destroying value.
Compared to 1 year ago, DOC has more shares outstanding
DOC has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DOC has remained at the same level compared to a year ago.
2.2 Solvency
DOC has an Altman-Z score of 0.36. This is a bad value and indicates that DOC is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of DOC (0.36) is comparable to the rest of the industry.
DOC has a debt to FCF ratio of 20.30. This is a negative value and a sign of low solvency as DOC would need 20.30 years to pay back of all of its debts.
DOC has a better Debt to FCF ratio (20.30) than 76.56% of its industry peers.
DOC has a Debt/Equity ratio of 1.20. This is a high value indicating a heavy dependency on external financing.
DOC's Debt to Equity ratio of 1.20 is in line compared to the rest of the industry. DOC outperforms 54.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.2 | ||
| Debt/FCF | 20.3 | ||
| Altman-Z | 0.36 |
ROIC/WACC0.35
WACC6.35%
2.3 Liquidity
DOC has a Current Ratio of 0.11. This is a bad value and indicates that DOC is not financially healthy enough and could expect problems in meeting its short term obligations.
DOC has a worse Current ratio (0.11) than 96.09% of its industry peers.
DOC has a Quick Ratio of 0.11. This is a bad value and indicates that DOC is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DOC (0.11) is worse than 96.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.11 | ||
| Quick Ratio | 0.11 |
3. Growth
3.1 Past
The earnings per share for DOC have decreased strongly by -57.45% in the last year.
Measured over the past years, DOC shows a very strong growth in Earnings Per Share. The EPS has been growing by 28.47% on average per year.
The Revenue has grown by 9.58% in the past year. This is quite good.
The Revenue has been growing by 16.84% on average over the past years. This is quite good.
EPS 1Y (TTM)-57.45%
EPS 3Y-16.9%
EPS 5Y28.47%
EPS Q2Q%-33.33%
Revenue 1Y (TTM)9.58%
Revenue growth 3Y12.51%
Revenue growth 5Y16.84%
Sales Q2Q%0.78%
3.2 Future
Based on estimates for the next years, DOC will show a decrease in Earnings Per Share. The EPS will decrease by -0.97% on average per year.
DOC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.64% yearly.
EPS Next Y-35.43%
EPS Next 2Y-11.73%
EPS Next 3Y-7.5%
EPS Next 5Y-0.97%
Revenue Next Year3.49%
Revenue Next 2Y3.05%
Revenue Next 3Y3.57%
Revenue Next 5Y4.64%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 90.20 indicates a quite expensive valuation of DOC.
The rest of the industry has a similar Price/Earnings ratio as DOC.
When comparing the Price/Earnings ratio of DOC to the average of the S&P500 Index (26.15), we can say DOC is valued expensively.
With a Price/Forward Earnings ratio of 66.15, DOC can be considered very expensive at the moment.
DOC's Price/Forward Earnings ratio is in line with the industry average.
DOC is valuated expensively when we compare the Price/Forward Earnings ratio to 36.22, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 90.2 | ||
| Fwd PE | 66.15 |
4.2 Price Multiples
DOC's Enterprise Value to EBITDA ratio is in line with the industry average.
71.09% of the companies in the same industry are more expensive than DOC, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.87 | ||
| EV/EBITDA | 13.72 |
4.3 Compensation for Growth
DOC's earnings are expected to decrease with -7.50% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)3.17
EPS Next 2Y-11.73%
EPS Next 3Y-7.5%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 6.70%, DOC is a good candidate for dividend investing.
DOC's Dividend Yield is a higher than the industry average which is at 6.34.
Compared to an average S&P500 Dividend Yield of 2.32, DOC pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.7% |
5.2 History
The dividend of DOC decreases each year by -2.76%.
DOC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-2.76%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DOC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DOC's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP-2176.08%
EPS Next 2Y-11.73%
EPS Next 3Y-7.5%
18.04
-0.15 (-0.82%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners96.35%
Inst Owner Change5.77%
Ins Owners0.22%
Ins Owner Change0.42%
Market Cap12.54B
Revenue(TTM)2.80B
Net Income(TTM)-38.93M
Analysts77.5
Price Target20.88 (15.74%)
Short Float %2.86%
Short Ratio2.43
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.7% |
Yearly Dividend1.28
Dividend Growth(5Y)-2.76%
DP-2176.08%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.17%
Min EPS beat(2)-19.41%
Max EPS beat(2)37.75%
EPS beat(4)2
Avg EPS beat(4)-12.11%
Min EPS beat(4)-79.16%
Max EPS beat(4)37.75%
EPS beat(8)5
Avg EPS beat(8)12.39%
EPS beat(12)7
Avg EPS beat(12)15.73%
EPS beat(16)10
Avg EPS beat(16)43.13%
Revenue beat(2)1
Avg Revenue beat(2)0.28%
Min Revenue beat(2)-0.37%
Max Revenue beat(2)0.94%
Revenue beat(4)3
Avg Revenue beat(4)0.74%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)2.05%
Revenue beat(8)6
Avg Revenue beat(8)1.89%
Revenue beat(12)8
Avg Revenue beat(12)-4.75%
Revenue beat(16)11
Avg Revenue beat(16)-3.38%
PT rev (1m)-1.64%
PT rev (3m)-4.15%
EPS NQ rev (1m)4.44%
EPS NQ rev (3m)-8.62%
EPS NY rev (1m)0.56%
EPS NY rev (3m)-10.05%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.25%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)-0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 90.2 | ||
| Fwd PE | 66.15 | ||
| P/S | 4.48 | ||
| P/FCF | 27.87 | ||
| P/OCF | 10.1 | ||
| P/B | 1.65 | ||
| P/tB | 1.79 | ||
| EV/EBITDA | 13.72 |
EPS(TTM)0.2
EY1.11%
EPS(NY)0.27
Fwd EY1.51%
FCF(TTM)0.65
FCFY3.59%
OCF(TTM)1.79
OCFY9.9%
SpS4.03
BVpS10.93
TBVpS10.05
PEG (NY)N/A
PEG (5Y)3.17
Graham Number7.01
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.2% | ||
| ROE | -0.51% | ||
| ROCE | 2.83% | ||
| ROIC | 2.23% | ||
| ROICexc | 2.25% | ||
| ROICexgc | 2.46% | ||
| OM | 18.19% | ||
| PM (TTM) | N/A | ||
| GM | 60.08% | ||
| FCFM | 16.06% |
ROA(3y)2.1%
ROA(5y)2.44%
ROE(3y)5.05%
ROE(5y)5.78%
ROIC(3y)2.19%
ROIC(5y)1.92%
ROICexc(3y)2.2%
ROICexc(5y)1.94%
ROICexgc(3y)2.39%
ROICexgc(5y)2.1%
ROCE(3y)2.77%
ROCE(5y)2.44%
ROICexgc growth 3Y3.4%
ROICexgc growth 5Y2.94%
ROICexc growth 3Y2.73%
ROICexc growth 5Y2.33%
OM growth 3Y-2.63%
OM growth 5Y-7.45%
PM growth 3Y-30.28%
PM growth 5Y20.4%
GM growth 3Y0.52%
GM growth 5Y-2.11%
F-Score4
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.2 | ||
| Debt/FCF | 20.3 | ||
| Debt/EBITDA | 5.78 | ||
| Cap/Depr | 73.87% | ||
| Cap/Sales | 28.24% | ||
| Interest Coverage | 1.93 | ||
| Cash Conversion | 78.53% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.11 | ||
| Quick Ratio | 0.11 | ||
| Altman-Z | 0.36 |
F-Score4
WACC6.35%
ROIC/WACC0.35
Cap/Depr(3y)101.04%
Cap/Depr(5y)178.11%
Cap/Sales(3y)35.69%
Cap/Sales(5y)67.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.45%
EPS 3Y-16.9%
EPS 5Y28.47%
EPS Q2Q%-33.33%
EPS Next Y-35.43%
EPS Next 2Y-11.73%
EPS Next 3Y-7.5%
EPS Next 5Y-0.97%
Revenue 1Y (TTM)9.58%
Revenue growth 3Y12.51%
Revenue growth 5Y16.84%
Sales Q2Q%0.78%
Revenue Next Year3.49%
Revenue Next 2Y3.05%
Revenue Next 3Y3.57%
Revenue Next 5Y4.64%
EBIT growth 1Y-12.91%
EBIT growth 3Y9.55%
EBIT growth 5Y8.14%
EBIT Next Year233.06%
EBIT Next 3Y53.58%
EBIT Next 5Y31.86%
FCF growth 1Y542.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.14%
OCF growth 3Y10.42%
OCF growth 5Y4.82%
HEALTHPEAK PROPERTIES INC / DOC FAQ
Can you provide the ChartMill fundamental rating for HEALTHPEAK PROPERTIES INC?
ChartMill assigns a fundamental rating of 3 / 10 to DOC.
Can you provide the valuation status for HEALTHPEAK PROPERTIES INC?
ChartMill assigns a valuation rating of 2 / 10 to HEALTHPEAK PROPERTIES INC (DOC). This can be considered as Overvalued.
What is the profitability of DOC stock?
HEALTHPEAK PROPERTIES INC (DOC) has a profitability rating of 4 / 10.
Can you provide the financial health for DOC stock?
The financial health rating of HEALTHPEAK PROPERTIES INC (DOC) is 2 / 10.
Can you provide the dividend sustainability for DOC stock?
The dividend rating of HEALTHPEAK PROPERTIES INC (DOC) is 5 / 10 and the dividend payout ratio is -2176.08%.